Journals / Journal of Medicine and Palliative Care / 2026 / Volume: 7 Issue: 5

Viral etiology, organ support requirements, and 28-day mortality in critically ill patients with PCR-confirmed respiratory viral pneumonia

Pages
—
Publication Date
2026-10-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings should be interpreted cautiously because of the retrospective design, small viral subgroups, and potential time dependent and confounding biases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Respiratory viral pneumonia is an important cause of acute respiratory failure requiring intensive care unit admission.
📊
Key Findings & Data:This study aimed to evaluate viral etiology, organ support requirements, microbiological findings, laboratory and radiologic characteristics, and 28-day mortality in critically ill patients with PCR-confirmed respiratory viral pneumonia.
💡
Conclusion & Impact:These findings should be interpreted cautiously because of the retrospective design, small viral subgroups, and potential time dependent and confounding biases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Pneumonia · viral · critical illness

Abstract

Aims: Respiratory viral pneumonia is an important cause of acute respiratory failure requiring intensive care unit admission. However, the clinical course of critically ill patients may be influenced not only by viral etiology but also by acute illness severity, organ support requirements, and microbiological co-detection. This study aimed to evaluate viral etiology, organ support requirements, microbiological findings, laboratory and radiologic characteristics, and 28-day mortality in critically ill patients with PCR-confirmed respiratory viral pneumonia. Methods: This single-center, record-based observational cohort study with retrospective data extraction included adult patients admitted directly from the emergency department to a tertiary-care medical ICU with acute respiratory failure, radiographic pneumonic infiltration, and PCR-confirmed respiratory viral pneumonia. Respiratory viral PCR samples were obtained during ICU admission using nasopharyngeal swabs. The primary outcome was 28-day all-cause mortality after ICU admission. Results: Seventy-nine patients were included. The median age was 72 years, and 46 patients were male. Twenty-eight-day mortality occurred in 26 patients (32.9%). Viral etiology was heterogeneous; influenza A was the most frequent pathogen, followed by rhinovirus/enterovirus and SARS-CoV-2. No statistically significant difference was observed between survivors and non-survivors according to individual viral categories; however, viral subgroup sizes were small. Non-survivors more frequently required invasive mechanical ventilation, vasopressor support, and continuous renal replacement therapy. Respiratory-source bacterial/fungal co-detection or infection was also more frequent among non-survivors. Baseline inflammatory biomarkers and parenchymal CT patterns did not differ significantly between survivors and non-survivors. Conclusion: In this small retrospective ICU cohort of patients with PCR-confirmed respiratory viral pneumonia, 28-day mortality was substantial. Non-survivors had higher rates of organ support requirements and respiratory-source bacterial/fungal co-detection or infection, while no significant mortality difference was observed across individual viral categories. These findings should be interpreted cautiously because of the retrospective design, small viral subgroups, and potential time dependent and confounding biases.

🔖

Cite This Article

Yalçınkaya, E., Kasapoğlu, U. S., Arıkan, H., Yıldırım, F. B., Karakurt, S. (2026). Viral etiology, organ support requirements, and 28-day mortality in critically ill patients with PCR-confirmed respiratory viral pneumonia. Journal of Medicine and Palliative Care, Volume: 7 Issue: 5. https://ajindex.com/articles/1668100

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (24)

  1. Fragkou PC, Moschopoulos CD, Karofylakis E, Kelesidis T, Tsiodras S. Update in viral infections in the intensive care unit. Front Med (Lausanne). 2021;8:575580. doi:10.3389/fmed.2021.575580
  2. Morris AC, Smielewska A. Viral infections in critical care: a narrative review. Anaesthesia. 2023;78(5):626-635. doi:10.1111/anae.15946
  3. Cia CT, Lin IT, Lee JC, Tsai HP, Wang JR, Ko WC. Respiratory viral infections in pragmatically selected adults in intensive care units. Sci Rep. 2021;11:20058. doi:10.1038/s41598-021-99608-y
  4. Vos LM, Bruning AHL, Reitsma JB, et al. Rapid molecular tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review of diagnostic accuracy and clinical impact studies. Clin Infect Dis. 2019;69(7):1243-1253. doi:10.1093/cid/ciz056
  5. Candel FJ, Salavert M, Cantón R, et al. The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document. Crit Care. 2024; 28(1):440. doi:10.1186/s13054-024-05224-3
  6. Wils J, Saegeman V, Schuermans A. Impact of multiplexed respiratory viral panels on infection control measures and antimicrobial stewardship: a review of the literature. Eur J Clin Microbiol Infect Dis. 2022;41(2):187-202. doi:10.1007/s10096-021-04375-3
  7. Brown M, Abeer F, Roe T, et al. Severe viral infections requiring intensive care unit admissions: aetiology, co-infections, respiratory interventions and outcomes. Infection. 2026;54(1):143-154. doi:10.1007/s15010-025-02637-2
  8. Halaçlı B, Hancı P, Ortaç Ersoy E, Öcal S, Tanrıöver MD, Topeli A. Influenza or other respiratory viruses: does it matter as the cause of acute respiratory failure in the critically-ill patients? Tuberk Toraks. 2020;68(4):388-398. doi:10.5578/tt.70350
  9. van der Bie S, Fluit RC, Neijzen T, et al. Is clinical outcome pathogen related? Characteristics and outcomes of ICU patients with severe acute respiratory infections: focusing on respiratory syncytial virus, human metapneumovirus, influenza virus, and parainfluenza virus. J Intensive Care Med. 2026;41(6):512-522. doi:10.1177/08850666251375938
  10. Do Rego H, Dessajan J, Le Hingrat Q, et al. Impact of respiratory viruses detection on outcomes in ventilated nosocomial pneumonia: an exposed/unexposed study. Ann Intensive Care. 2025;15(1):172. doi:10.1186/s13613-025-01600-6
  11. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007; 147(8):573-577. doi:10.7326/0003-4819-147-8-200710160-00010
  12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. doi:10.1016/0021-9681(87)90171-8
  13. Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489-495. doi:10.1503/cmaj.050051
  14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-829.
  15. Vincent JL, Moreno R, Takala J, et al. The SOFA score to describe organ dysfunction/failure. Intensive Care Med. 1996;22(7):707-710. doi:10.1007/BF01709751
  16. Cataudella E, Giraffa CM, Di Marca S, et al. Neutrophil-to-lymphocyte ratio: an emerging marker predicting prognosis in elderly adults with community-acquired pneumonia. J Am Geriatr Soc. 2017;65(8):1796-1801. doi:10.1111/jgs.14894
  17. Djordjevic D, Rondovic G, Surbatovic M, et al. Neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume-to-platelet count ratio as biomarkers in critically ill and injured patients: which ratio to choose to predict outcome and nature of bacteremia? Mediators Inflamm. 2018; 2018:3758068. doi:10.1155/2018/3758068
  18. Truong QA, Massaro JM, Rogers IS, et al. Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham Heart Study. Circ Cardiovasc Imaging. 2012;5(1):147-154. doi:10.1161/CIRCIMAGING.111.968610
  19. Aziza E, Slemko J, Zapernick L, Smith SW, Lee N, Sligl WI. Outcomes among critically ill adults with influenza infection. J Assoc Med Microbiol Infect Dis Can. 2021;6(4):269-277. doi:10.3138/jammi-2021-0011
  20. Carbonell R, Moreno G, Martín-Loeches I, et al. Prognostic value of procalcitonin and C-reactive protein in 1608 critically ill patients with severe influenza pneumonia. Antibiotics (Basel). 2021;10(4):350. doi:10.3390/antibiotics10040350
  21. Galli F, Bindo F, Motos A, et al. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients. Intensive Care Med. 2023;49(8):934-945. doi:10.1007/s00134-023-07161-1
  22. Altmayer S, Zanon M, Pacini GS, et al. Comparison of the computed tomography findings in COVID-19 and other viral pneumonia in immunocompetent adults: a systematic review and meta-analysis. Eur Radiol. 2020;30(12):6485-6496. doi:10.1007/s00330-020-07018-x
  23. Stefanidis K, Konstantelou E, Constantinou A, et al. Radiological, epidemiological and clinical patterns of pulmonary viral infections. Eur J Radiol. 2021;136:109548. doi:10.1016/j.ejrad.2021.109548
  24. Scarpato BM, Locke BW, Bledsoe J, et al. The association between pulmonary artery enlargement and mortality in an emergency department population undergoing computed tomography pulmonary angiography. Pulm Circ. 2023;13(2):e12225. doi:10.1002/pul2.12225